주식 시장 뉴스

씨티, 베라더믹스(Veradermics, Incorporated)(MANE)에 대해 강세 유지

Citi Remains Bullish on Veradermics, Incorporated (MANE)

The panel is divided on MANE's potential. While some see promise in its Phase 2/3 Part A data and the …

Ripple (XRP), 올해 10건의 주요 계약 체결: 각 파트너십 성적표 공개

Ripple (XRP) Has Closed 10 Major Deals This Year: Here’s the Scoreboard for Each Partnership

Despite Ripple's infrastructure wins, XRP's price performance remains lackluster due to regulatory uncertainty and limited token utility. The market is …

JPMorgan, Erasca(ERAS) 주식을 현재 수준에서 매수 추천

JPMorgan Recommends Buying Erasca (ERAS) Stock at Current Levels

The panel consensus is bearish on Erasca (ERAS), with concerns around 'not fully clean' Phase 1 data, safety caveats, and …

Stifel, Tango Therapeutics (TNGX)에 대해 강세 전망 유지

Stifel Remains Bullish on Tango Therapeutics (TNGX)

The panel's discussion on TNGX revolves around the potential of its PRMT5/RAS(ON) combo in pancreatic cancer, with a cash runway …

Leerink Partners는 Oruka Therapeutics, Inc. (ORKA)의 목표 주가 (PT)를 상향 조정했습니다.

Leerink Partners Lifts PT on Oruka Therapeutics, Inc. (ORKA)

ORKA-001's Phase 2a results are impressive, but its path to market is uncertain due to manufacturing challenges, competition, and commercial …

AnaptysBio (ANAB)는 2026년까지 가장 실적이 좋은 헬스케어 주식 중 하나일까요?

Is AnaptysBio (ANAB) One of the Best Performing Healthcare Stocks so Far in 2026?

The panel is divided on ANAB's spinoff of TRAX, with some seeing it as a value-enhancing move that separates stable …

Revolution Medicines (RVMD), 다락소나시브에 대한 FDA의 "진행 가능" 서신 접수

Revolution Medicines (RVMD) Receives FDA’s “Safe to Proceed” Letter for Daraxonrasib

The panel is mixed on RVMD's 'safe to proceed' EAP, with concerns about the lack of efficacy data, manufacturing challenges, …

RBC, Acadia Healthcare Company(ACHC) 목표 주가 상향 조정, 1분기 실적 호조에 따른

RBC Capital Lifts PT on Acadia Healthcare Company (ACHC) Following Q1 Earnings Beat

While ACHC's Q1 earnings beat and upgrades suggest potential for EBITDA improvement and a 'harvest' from underperforming facilities, the consensus …

Twist Bioscience Corporation (TWST) Announces Q2 2026 Financial Results

The panelists agree that Twist Bioscience has shown operational momentum with 13 consecutive quarters of growth and a 19% YoY …

골드만삭스, 브로드컴 주식 전망 재조정

Goldman Sachs resets Broadcom stock forecast

The panel is divided on Broadcom's VMware integration, with bulls focusing on potential margin expansion and AI momentum, while bears …

RBC 캐피탈이 CG 온콜로지 (CGON)에 PT를 올리며, PIVOT-006를 복잡한 촉매로 부른다

RBC Capital Lifts PT on CG Oncology (CGON), Calls PIVOT-006 a Complex Catalyst

CG Oncology's stock performance is heavily reliant on the June PIVOT-006 data, with a high risk of a 'sell the …

W.W. 그레이너 Q1 수익 호출 요약

W.W. Grainger Q1 Earnings Call Highlights

Panelists have mixed views on Grainger's Q1 results and future prospects. While some highlight the impressive EPS growth and margin …